MedPath

A comparative clinical study to evaluate the effect of Shalmali Ghritha and Bola Baddha Rasa in Asrigdara (DUB)

Phase 3
Conditions
Health Condition 1: N938- Other specified abnormal uterine and vaginal bleeding
Registration Number
CTRI/2023/10/058973
Lead Sponsor
Akshata Mallikarjun Mudalagi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Raja Atipravarthi – Excessive Bleeding ( >/ 6 pads fully soaked per day ).

2.Deerga kala anubandhi – Prolonged Bleeding ( >/ 8 days) , pervious H/O atleast 2 consecutive cycles.

3.Vedana – Pain

4.Age : 20 - 45 years

5.Patient with HB% > 8gm%

6.Both married and unmarried

Exclusion Criteria

1.Patient with history of DM, HTN, Bleeding disorders and other systemic disorders.

2.Pregnant and Lactating females.

3.Any pelvic pathologies like Endometriosis, Fibroids, Tumor, Inflammation, Benign and Malignant growth in uterus.

4.Post Abortal Bleeding.

5.Endocrinal disorders like Thyroid Dysfunction, PCOS .

6.IUCD and OCP user.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Prolonged cycle (YES/NO) 2.Duration of menstrual bleeding <br/ ><br>3.Excessive bleeding (YES/NO) 4.Amount of menstrual bleeding <br/ ><br>5.Pain <br/ ><br>Timepoint: During treatment 3rd day & 11th day <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1.Prolonged cycle (YES/NO) 2.Duration of menstrual bleeding <br/ ><br>3.Excessive bleeding (YES/NO) 4.Amount of menstrual bleeding <br/ ><br>5.Pain <br/ ><br>Timepoint: After treatment 3rd day & 11th day of next 2 consecutive menstrual cycle.
© Copyright 2025. All Rights Reserved by MedPath